Asset
ZILGANERSEN
Ionis Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04849741 | phase3 | active_not_recruiting | 2021-06-01 | 2025-08-22 | Ionis Pharmaceuticals, Inc. | A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD) |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 220210 | NDA | IONIS PHARMS INC |
Marketed products (1)
- ZANVASTRO